Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Biliary Tract Neoplasms 3Uterine Cervical Neoplasms 1Rectal Neoplasms 1Rare Tumour 1Osteosarcoma 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumor 1Advanced Renal Cell Carcinoma (aRCC) 1Advanced Refractory Solid Tumors 1

Interventions

Cisplatin 7Paclitaxel 5Radiotherapy 4Platinum 3zimberelimab 2pembrolizumab 2nimotuzumab 2lenvatinib 2camrelizumab 2Taxes 2Injections 2Human Papillomavirus Recombinant Vaccine nonavalent 2Drug Therapy 2Carboplatin 2Brachytherapy 2trilaciclib 1toripalimab 1tislelizumab 1sintilimab 1neratinib 1fludarabine 1envafolimab 1Watchful Waiting 1Ultrasonography, Doppler 1Transurethral Resection of Prostate 1Therapeutics 1Telemedicine 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Uterine Cervical Neoplasms × envafolimab × Clear all
NCT05799469 2023-04-05

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Chongqing University Cancer Hospital

Phase 2 Not yet recruiting
36 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡